(BPT) - Cancer is poised to become the number one killer in the U.S., and hundreds of thousands of patients need people like you to participate in clinical research trials evaluating new treatment options. But you don’t have to be sick to be part.
Orca Bio, a clinical-stage biotechnology company developing purified, high-precision cell therapies for the treatment of cancer, genetic blood disorders and autoimmune diseases, today announced that
Juno's lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ MorphImmune, Inc., a private platform company that is advancing a highly specific targeting technology that uses a ligand-linked payload to.